Authors: PEEST D DEICHER H FETT W HARMS P BRAUN HJ PLANKER M KINDLER U KLINKENSTEIN C SCHAFER E SCHUMACHER K SIECKE H

Citation: D. Peest et al., PYRIDINIUM CROSS-LINKS IN MULTIPLE-MYELOMA - CORRELATION WITH CLINICAL-PARAMETERS AND USE FOR MONITORING OF INTRAVENOUS CLODRONATE THERAPY - A PILOT-STUDY OF THE GERMAN MYELOMA TREATMENT GROUP (GMTG), European journal of cancer, 32A(12), 1996, pp. 2053-2057

Authors: PEEST D DEICHER H COLDEWEY R LEO R BARTL R BARTELS H BRAUN HJ FETT W FISCHER JT GOBEL B HARMS P HENKE R HOFFMANN L KREUSER ED MAIER WD MEIER CR OERTEL J PETIT M PLANKER M PLATZECK C RESPONDEK M SCHAFER E SCHUMACHER K STENNES M STENZINGER W TIRIER C WAGNER H WEH HJ VONWUSSOW P WYSK J

Citation: D. Peest et al., A COMPARISON OF POLYCHEMOTHERAPY AND MELPHALAN PREDNISONE FOR PRIMARYREMISSION INDUCTION, AND INTERFERON-ALPHA FOR MAINTENANCE TREATMENT, IN MULTIPLE-MYELOMA - A PROSPECTIVE TRIAL OF THE GERMAN MYELOMA TREATMENT GROUP, European journal of cancer, 31A(2), 1995, pp. 146-151

Authors: DUBOIS A VACH W CRAMERGIRAUD U THOMSSEN C GLAUBITZ M FIOLA M AUGENER W BARTSCH W BERGMANN F BIERBAUM W KRAPP J BONING L BONGARTZ U BRUNTSCH U VONBULTZINGSLOWEN F DIETL J FUGER T FULLE HH GATZEMEIER U GROPP C HARTLAPP H HERSCHLEIN HJ HOLTKAMP W HURST U JANICKE F KAUKEL E KLEEBERG U ENGEL E KRAFFT W KUHNLE H LINDEMANN H MARSCHNER N MEERPOHL HG NIEDERLE N OSIEKA R PLANKER M RIESS H SCHMIDT M SCHMOLL HJ SCHUNEMANN H WEINGARTJESSE B WEITZEL H WESTERHAUSEN M WINKELMANN M

Citation: A. Dubois et al., PATTERN OF CARBOPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6(5), 1995, pp. 645-651

Authors: DIEHL V LOEFFLER M PFREUNDSCHUH M RUEHL U HASENCLEVER D NISTERSBACKES H SIEBER M SMITH K TESCH H GEILEN W ADLER M BARTELS H BRANDENBURG U DIEZLER P DOELKEN G ENZIAN J FUCHS R GASSMANN W GERHARTZ H HAGENAUKAMP U HECHT T HILLER E HINKELBEIN H LATHAN B KIRCHNER H KUEHN G KUERTEN H LOOS U MAKOSKI B OERTEL W PETSCH S PFAB R PFLUEGER H PLANKER M ROHLOFF R SACK H SAMANDARI S SAUER R SCHALK K SCHMITZ G SCHOPPE W SCHWIEDER G SZEPESI S TEICHMANN J WILHELMY W WORST P FISCHER R GEORGII A HUEBNER K SCHWARZE EW

Citation: V. Diehl et al., FURTHER CHEMOTHERAPY VERSUS LOW-DOSE INVOLVED-FIELD RADIOTHERAPY AS CONSOLIDATION OF COMPLETE REMISSION AFTER 6 CYCLES OF ALTERNATING CHEMOTHERAPY IN PATIENTS WITH ADVANCED HODGKINS-DISEASE, Annals of oncology, 6(9), 1995, pp. 901-910

Authors: PEEST D COLDEWEY R DEICHER H SAILER M VYKOUPIL C LEO R GEORGII A KAROW J HOEPPNER E DIEHL V ESSERS U GAMM H GLUCK S GORG K GRAMATZKI M HAUSWALDT C HEILMANN E HIEMEYER V KEYSERLINGK HJ KINDLER A OERTEL J PLANKER M REINOLD HM SCHAFER E SCHUMACHER K TIRIER C URBANITZ D SUCHY BR WAHRISCH J

Citation: D. Peest et al., PROGNOSTIC VALUE OF CLINICAL, LABORATORY, AND HISTOLOGICAL CHARACTERISTICS IN MULTIPLE-MYELOMA - IMPROVED DEFINITION OF RISK GROUPS, European journal of cancer, 29A(7), 1993, pp. 978-983